| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 1.27e-05 | 5 | 23 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.27e-05 | 5 | 23 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 2.66e-05 | 7 | 23 | 2 | GO:0015247 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 4.55e-05 | 9 | 23 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | transporter activity | 6.03e-05 | 1289 | 23 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 1.15e-04 | 14 | 23 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 1.51e-04 | 16 | 23 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | floppase activity | 1.51e-04 | 16 | 23 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | flippase activity | 1.71e-04 | 17 | 23 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | lamin binding | 2.14e-04 | 19 | 23 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.59e-04 | 109 | 23 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 2.62e-04 | 1180 | 23 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.71e-04 | 28 | 23 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 6.85e-04 | 152 | 23 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.06e-03 | 42 | 23 | 2 | GO:0042887 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.08e-03 | 178 | 23 | 3 | GO:0015399 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.15e-03 | 182 | 23 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.19e-03 | 184 | 23 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.22e-03 | 45 | 23 | 2 | GO:0043495 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.44e-03 | 49 | 23 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.48e-03 | 758 | 23 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.49e-03 | 441 | 23 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.56e-03 | 51 | 23 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.72e-03 | 459 | 23 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.81e-03 | 793 | 23 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | channel activity | 2.81e-03 | 525 | 23 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.83e-03 | 526 | 23 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 3.26e-03 | 74 | 23 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.92e-03 | 614 | 23 | 4 | GO:0140657 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 6.10e-03 | 102 | 23 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.41e-03 | 334 | 23 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 6.48e-03 | 664 | 23 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.90e-03 | 343 | 23 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | potassium channel activity | 9.45e-03 | 128 | 23 | 2 | GO:0005267 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.11e-02 | 775 | 23 | 4 | GO:0017111 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.12e-02 | 140 | 23 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.45e-02 | 839 | 23 | 4 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.45e-02 | 840 | 23 | 4 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.45e-02 | 840 | 23 | 4 | GO:0016818 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.57e-02 | 167 | 23 | 2 | GO:0015079 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.57e-02 | 465 | 23 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.64e-02 | 171 | 23 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.68e-02 | 477 | 23 | 3 | GO:0022804 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.06e-02 | 193 | 23 | 2 | GO:0015276 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.12e-02 | 196 | 23 | 2 | GO:0005319 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.14e-02 | 197 | 23 | 2 | GO:0022834 | |
| GeneOntologyBiologicalProcess | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration | 4.23e-06 | 3 | 25 | 2 | GO:0021817 | |
| GeneOntologyBiologicalProcess | nuclear matrix anchoring at nuclear membrane | 4.23e-06 | 3 | 25 | 2 | GO:0090292 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 8.45e-06 | 4 | 25 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 1.41e-05 | 5 | 25 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | nuclear migration along microtubule | 1.41e-05 | 5 | 25 | 2 | GO:0030473 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 1.94e-05 | 1374 | 25 | 9 | GO:0006811 | |
| GeneOntologyBiologicalProcess | cell motility involved in cerebral cortex radial glia guided migration | 2.95e-05 | 7 | 25 | 2 | GO:0021814 | |
| GeneOntologyBiologicalProcess | aminophospholipid translocation | 2.95e-05 | 7 | 25 | 2 | GO:0140331 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 4.39e-05 | 1157 | 25 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | aminophospholipid transport | 5.05e-05 | 9 | 25 | 2 | GO:0015917 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.37e-04 | 1000 | 25 | 7 | GO:0030001 | |
| GeneOntologyBiologicalProcess | oligopeptide transmembrane transport | 1.90e-04 | 17 | 25 | 2 | GO:0035672 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 2.42e-04 | 101 | 25 | 3 | GO:0002028 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.14e-04 | 275 | 25 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 3.51e-04 | 23 | 25 | 2 | GO:0006857 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in nucleus | 4.50e-04 | 26 | 25 | 2 | GO:0051457 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 6.01e-04 | 30 | 25 | 2 | GO:0021801 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 6.01e-04 | 30 | 25 | 2 | GO:0022030 | |
| GeneOntologyBiologicalProcess | nuclear migration | 7.73e-04 | 34 | 25 | 2 | GO:0007097 | |
| GeneOntologyBiologicalProcess | centrosome localization | 8.19e-04 | 35 | 25 | 2 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 8.66e-04 | 36 | 25 | 2 | GO:0061842 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 9.63e-04 | 162 | 25 | 3 | GO:0015748 | |
| GeneOntologyBiologicalProcess | cerebral cortex radially oriented cell migration | 1.18e-03 | 42 | 25 | 2 | GO:0021799 | |
| GeneOntologyBiologicalProcess | maintenance of location | 1.23e-03 | 396 | 25 | 4 | GO:0051235 | |
| GeneOntologyBiologicalProcess | nucleus localization | 1.29e-03 | 44 | 25 | 2 | GO:0051647 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in organelle | 1.47e-03 | 47 | 25 | 2 | GO:0072595 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.79e-03 | 1115 | 25 | 6 | GO:0034220 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 2.01e-03 | 55 | 25 | 2 | GO:0045332 | |
| GeneOntologyBiologicalProcess | learning | 2.08e-03 | 212 | 25 | 3 | GO:0007612 | |
| GeneOntologyBiologicalProcess | cerebral cortex cell migration | 2.09e-03 | 56 | 25 | 2 | GO:0021795 | |
| GeneOntologyBiologicalProcess | lipid translocation | 2.39e-03 | 60 | 25 | 2 | GO:0034204 | |
| GeneOntologyBiologicalProcess | nuclear envelope organization | 2.63e-03 | 63 | 25 | 2 | GO:0006998 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.80e-03 | 65 | 25 | 2 | GO:0097035 | |
| GeneOntologyBiologicalProcess | lipid transport | 3.01e-03 | 506 | 25 | 4 | GO:0006869 | |
| GeneOntologyCellularComponent | transporter complex | 3.73e-05 | 550 | 25 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 7.50e-05 | 11 | 25 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 7.50e-05 | 11 | 25 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 7.50e-05 | 11 | 25 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 7.50e-05 | 11 | 25 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.24e-04 | 14 | 25 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.85e-04 | 378 | 25 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.06e-03 | 462 | 25 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.06e-03 | 462 | 25 | 4 | GO:0098852 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 2.25e-03 | 59 | 25 | 2 | GO:0005637 | |
| GeneOntologyCellularComponent | vacuolar membrane | 2.89e-03 | 507 | 25 | 4 | GO:0005774 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.23e-03 | 523 | 25 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 3.54e-03 | 1293 | 25 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 3.62e-03 | 1299 | 25 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 4.03e-03 | 1327 | 25 | 6 | GO:0042175 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 5.27e-03 | 91 | 25 | 2 | GO:0008076 | |
| GeneOntologyCellularComponent | specific granule membrane | 5.27e-03 | 91 | 25 | 2 | GO:0035579 | |
| GeneOntologyCellularComponent | potassium channel complex | 6.83e-03 | 104 | 25 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | membrane protein complex | 7.27e-03 | 1498 | 25 | 6 | GO:0098796 | |
| GeneOntologyCellularComponent | nuclear membrane | 8.08e-03 | 349 | 25 | 3 | GO:0031965 | |
| Domain | NKAIN | 7.45e-09 | 4 | 24 | 3 | PF05640 | |
| Domain | Na/K-Atpase_Interacting | 7.45e-09 | 4 | 24 | 3 | IPR008516 | |
| Domain | SUN | 2.37e-05 | 6 | 24 | 2 | PS51469 | |
| Domain | SUN_dom | 3.31e-05 | 7 | 24 | 2 | IPR012919 | |
| Domain | Sad1_UNC | 3.31e-05 | 7 | 24 | 2 | PF07738 | |
| Domain | P_typ_ATPase_c | 1.43e-04 | 14 | 24 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.43e-04 | 14 | 24 | 2 | IPR032631 | |
| Domain | PhoLip_ATPase_C | 1.43e-04 | 14 | 24 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.43e-04 | 14 | 24 | 2 | PF16209 | |
| Domain | P-type_ATPase_IV | 1.43e-04 | 14 | 24 | 2 | IPR006539 | |
| Domain | ABC_membrane | 4.29e-04 | 24 | 24 | 2 | PF00664 | |
| Domain | ABC_TM1F | 5.86e-04 | 28 | 24 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 5.86e-04 | 28 | 24 | 2 | IPR011527 | |
| Domain | - | 7.67e-04 | 32 | 24 | 2 | 2.70.150.10 | |
| Domain | - | 7.67e-04 | 32 | 24 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 9.18e-04 | 35 | 24 | 2 | IPR023299 | |
| Domain | ATPASE_E1_E2 | 9.71e-04 | 36 | 24 | 2 | PS00154 | |
| Domain | ATPase_P-typ_P_site | 9.71e-04 | 36 | 24 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 9.71e-04 | 36 | 24 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.03e-03 | 37 | 24 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.03e-03 | 37 | 24 | 2 | PF00122 | |
| Domain | ABC_transporter_CS | 1.32e-03 | 42 | 24 | 2 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 1.72e-03 | 48 | 24 | 2 | PS50893 | |
| Domain | ABC_tran | 1.72e-03 | 48 | 24 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 1.79e-03 | 49 | 24 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 1.87e-03 | 50 | 24 | 2 | IPR003439 | |
| Domain | Channel_four-helix_dom | 2.42e-03 | 57 | 24 | 2 | IPR027359 | |
| Domain | - | 2.42e-03 | 57 | 24 | 2 | 1.20.120.350 | |
| Domain | - | 3.04e-03 | 64 | 24 | 2 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 4.59e-03 | 79 | 24 | 2 | IPR023214 | |
| Domain | Ion_trans_dom | 9.34e-03 | 114 | 24 | 2 | IPR005821 | |
| Domain | Ion_trans | 9.34e-03 | 114 | 24 | 2 | PF00520 | |
| Domain | AAA+_ATPase | 1.46e-02 | 144 | 24 | 2 | IPR003593 | |
| Domain | AAA | 1.46e-02 | 144 | 24 | 2 | SM00382 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 6.56e-05 | 681 | 16 | 6 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.01e-04 | 736 | 16 | 6 | M27287 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.51e-04 | 176 | 16 | 3 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.06e-03 | 183 | 16 | 3 | M997 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.11e-03 | 44 | 16 | 2 | M11911 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.73e-03 | 55 | 16 | 2 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.86e-03 | 57 | 16 | 2 | MM15643 | |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | 3.45e-03 | 78 | 16 | 2 | M1061 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 5.39e-03 | 98 | 16 | 2 | MM14545 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 5.49e-03 | 99 | 16 | 2 | MM14986 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.92e-03 | 335 | 16 | 3 | MM14503 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 5.93e-03 | 103 | 16 | 2 | M1073 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 5.93e-03 | 103 | 16 | 2 | M758 | |
| Pubmed | A novel family of transmembrane proteins interacting with beta subunits of the Na,K-ATPase. | 1.15e-08 | 7 | 25 | 3 | 17606467 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10375507 | ||
| Pubmed | SUN proteins facilitate the removal of membranes from chromatin during nuclear envelope breakdown. | 4.96e-07 | 2 | 25 | 2 | 24662567 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25210889 | ||
| Pubmed | SUN1/2 controls macrophage polarization via modulating nuclear size and stiffness. | 4.96e-07 | 2 | 25 | 2 | 37828059 | |
| Pubmed | Differential incorporation of SUN-domain proteins into LINC complexes is coupled to gene expression. | 4.96e-07 | 2 | 25 | 2 | 29813079 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 26035387 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24586178 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 17132086 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 31935926 | ||
| Pubmed | Inner nuclear envelope proteins SUN1 and SUN2 play a prominent role in the DNA damage response. | 4.96e-07 | 2 | 25 | 2 | 22863315 | |
| Pubmed | Structural conservation of the autoinhibitory domain in SUN proteins. | 4.96e-07 | 2 | 25 | 2 | 29408528 | |
| Pubmed | Nuclear-cytoskeletal linkages facilitate cross talk between the nucleus and intercellular adhesions. | 4.96e-07 | 2 | 25 | 2 | 25963820 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28747499 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 19843581 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23348741 | ||
| Pubmed | Nuclear envelope-associated endosomes deliver surface proteins to the nucleus. | 1.49e-06 | 3 | 25 | 2 | 26356418 | |
| Pubmed | Jaw1/LRMP has a role in maintaining nuclear shape via interaction with SUN proteins. | 1.49e-06 | 3 | 25 | 2 | 29878215 | |
| Pubmed | The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal. | 2.97e-06 | 4 | 25 | 2 | 33686165 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 2.97e-06 | 4 | 25 | 2 | 20108321 | |
| Pubmed | Coupling of the nucleus and cytoplasm: role of the LINC complex. | 2.97e-06 | 4 | 25 | 2 | 16380439 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 28966089 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 33779546 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 19933576 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 18396275 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 4.95e-06 | 5 | 25 | 2 | 22632968 | |
| Pubmed | A molecular mechanism for LINC complex branching by structurally diverse SUN-KASH 6:6 assemblies. | 4.95e-06 | 5 | 25 | 2 | 33393904 | |
| Pubmed | 7.38e-06 | 176 | 25 | 4 | 28692057 | ||
| Pubmed | Samp1 is functionally associated with the LINC complex and A-type lamina networks. | 7.43e-06 | 6 | 25 | 2 | 21610090 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 19509342 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 22872573 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 1.84e-05 | 468 | 25 | 5 | 31056421 | |
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 2.22e-05 | 10 | 25 | 2 | 12958361 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 2.22e-05 | 10 | 25 | 2 | 28533284 | |
| Pubmed | 2.62e-05 | 504 | 25 | 5 | 34432599 | ||
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 21914794 | ||
| Pubmed | Excess LINC complexes impair brain morphogenesis in a mouse model of recessive TOR1A disease. | 3.26e-05 | 12 | 25 | 2 | 29868845 | |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 3.85e-05 | 13 | 25 | 2 | 11015572 | |
| Pubmed | 3.85e-05 | 13 | 25 | 2 | 21177258 | ||
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 19874786 | ||
| Pubmed | 4.69e-05 | 952 | 25 | 6 | 38569033 | ||
| Pubmed | 5.22e-05 | 101 | 25 | 3 | 9872452 | ||
| Pubmed | 5.87e-05 | 299 | 25 | 4 | 37931956 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 9250876 | ||
| Pubmed | 1.14e-04 | 22 | 25 | 2 | 8894702 | ||
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 2.43e-04 | 32 | 25 | 2 | 37067297 | |
| Pubmed | 5.04e-04 | 46 | 25 | 2 | 30419336 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 5.49e-04 | 1496 | 25 | 6 | 32877691 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 6.12e-04 | 233 | 25 | 3 | 32290105 | |
| Interaction | TTYH1 interactions | 4.21e-08 | 300 | 24 | 7 | int:TTYH1 | |
| Interaction | DNAJC25 interactions | 1.83e-05 | 284 | 24 | 5 | int:DNAJC25 | |
| Interaction | LRP3 interactions | 2.32e-05 | 47 | 24 | 3 | int:LRP3 | |
| Interaction | EMD interactions | 2.65e-05 | 789 | 24 | 7 | int:EMD | |
| Interaction | CRELD1 interactions | 3.86e-05 | 163 | 24 | 4 | int:CRELD1 | |
| Interaction | RHOD interactions | 4.43e-05 | 572 | 24 | 6 | int:RHOD | |
| Interaction | RHOC interactions | 4.98e-05 | 584 | 24 | 6 | int:RHOC | |
| Interaction | TMT1A interactions | 5.61e-05 | 359 | 24 | 5 | int:TMT1A | |
| Interaction | DNAJC1 interactions | 5.76e-05 | 361 | 24 | 5 | int:DNAJC1 | |
| Interaction | ST7 interactions | 5.84e-05 | 362 | 24 | 5 | int:ST7 | |
| Interaction | BSCL2 interactions | 6.46e-05 | 186 | 24 | 4 | int:BSCL2 | |
| Interaction | RHOG interactions | 6.59e-05 | 910 | 24 | 7 | int:RHOG | |
| Interaction | TEX2 interactions | 6.60e-05 | 187 | 24 | 4 | int:TEX2 | |
| Interaction | RAC3 interactions | 6.87e-05 | 619 | 24 | 6 | int:RAC3 | |
| Interaction | NRM interactions | 8.39e-05 | 72 | 24 | 3 | int:NRM | |
| Interaction | OR10H2 interactions | 8.39e-05 | 72 | 24 | 3 | int:OR10H2 | |
| Interaction | CTDNEP1 interactions | 9.47e-05 | 75 | 24 | 3 | int:CTDNEP1 | |
| Interaction | OTULINL interactions | 9.92e-05 | 405 | 24 | 5 | int:OTULINL | |
| Interaction | RAC2 interactions | 1.10e-04 | 674 | 24 | 6 | int:RAC2 | |
| Interaction | CA9 interactions | 1.13e-04 | 215 | 24 | 4 | int:CA9 | |
| Interaction | SYNE2 interactions | 1.22e-04 | 219 | 24 | 4 | int:SYNE2 | |
| Interaction | RND2 interactions | 1.46e-04 | 440 | 24 | 5 | int:RND2 | |
| Interaction | EVC2 interactions | 1.52e-04 | 88 | 24 | 3 | int:EVC2 | |
| Interaction | DNAJC16 interactions | 1.54e-04 | 233 | 24 | 4 | int:DNAJC16 | |
| Interaction | RXFP1 interactions | 1.63e-04 | 90 | 24 | 3 | int:RXFP1 | |
| Interaction | SSR1 interactions | 1.68e-04 | 453 | 24 | 5 | int:SSR1 | |
| Interaction | GJD3 interactions | 1.69e-04 | 454 | 24 | 5 | int:GJD3 | |
| Interaction | PLD3 interactions | 1.90e-04 | 246 | 24 | 4 | int:PLD3 | |
| Interaction | ZACN interactions | 1.97e-04 | 96 | 24 | 3 | int:ZACN | |
| Interaction | NUP155 interactions | 2.13e-04 | 477 | 24 | 5 | int:NUP155 | |
| Interaction | SLC25A46 interactions | 2.60e-04 | 267 | 24 | 4 | int:SLC25A46 | |
| Interaction | CSGALNACT2 interactions | 2.64e-04 | 106 | 24 | 3 | int:CSGALNACT2 | |
| Interaction | SEC62 interactions | 2.80e-04 | 506 | 24 | 5 | int:SEC62 | |
| Interaction | ZNRF4 interactions | 2.95e-04 | 110 | 24 | 3 | int:ZNRF4 | |
| Interaction | RHOH interactions | 2.96e-04 | 512 | 24 | 5 | int:RHOH | |
| Interaction | RHOA interactions | 3.66e-04 | 1199 | 24 | 7 | int:RHOA | |
| Interaction | LRRC59 interactions | 3.75e-04 | 845 | 24 | 6 | int:LRRC59 | |
| Interaction | C3orf52 interactions | 4.30e-04 | 305 | 24 | 4 | int:C3orf52 | |
| Interaction | SMPD3 interactions | 4.34e-04 | 26 | 24 | 2 | int:SMPD3 | |
| Interaction | RAB7A interactions | 4.83e-04 | 886 | 24 | 6 | int:RAB7A | |
| Interaction | RAB35 interactions | 4.96e-04 | 573 | 24 | 5 | int:RAB35 | |
| Interaction | TMEM30A interactions | 5.03e-04 | 132 | 24 | 3 | int:TMEM30A | |
| Interaction | TCTN3 interactions | 6.06e-04 | 334 | 24 | 4 | int:TCTN3 | |
| Interaction | RAB5C interactions | 6.11e-04 | 600 | 24 | 5 | int:RAB5C | |
| Interaction | LMNB1 interactions | 6.59e-04 | 610 | 24 | 5 | int:LMNB1 | |
| Interaction | SEMA7A interactions | 6.60e-04 | 32 | 24 | 2 | int:SEMA7A | |
| Interaction | SEC63 interactions | 7.07e-04 | 348 | 24 | 4 | int:SEC63 | |
| Interaction | LNPK interactions | 7.61e-04 | 355 | 24 | 4 | int:LNPK | |
| Interaction | RHOJ interactions | 7.79e-04 | 633 | 24 | 5 | int:RHOJ | |
| Interaction | PIGH interactions | 8.95e-04 | 161 | 24 | 3 | int:PIGH | |
| Interaction | B3GAT1 interactions | 9.52e-04 | 377 | 24 | 4 | int:B3GAT1 | |
| Interaction | RHOF interactions | 1.03e-03 | 673 | 24 | 5 | int:RHOF | |
| Interaction | TEX264 interactions | 1.18e-03 | 177 | 24 | 3 | int:TEX264 | |
| Interaction | TMEM17 interactions | 1.23e-03 | 404 | 24 | 4 | int:TMEM17 | |
| Interaction | RAC1 interactions | 1.26e-03 | 1063 | 24 | 6 | int:RAC1 | |
| Interaction | PIK3CA interactions | 1.40e-03 | 188 | 24 | 3 | int:PIK3CA | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.88e-03 | 454 | 25 | 3 | chr11q13 | |
| GeneFamily | Na+/K+ transporting ATPase interacting | 8.93e-10 | 4 | 12 | 3 | 659 | |
| GeneFamily | ATPase phospholipid transporting | 4.22e-05 | 15 | 12 | 2 | 1210 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | 1.12e-06 | 891 | 25 | 8 | M45033 | |
| Coexpression | DESCARTES_FETAL_STOMACH_ENS_GLIA | 1.29e-05 | 48 | 25 | 3 | M40307 | |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_UP | 2.03e-05 | 172 | 25 | 4 | M5388 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 7.95e-05 | 244 | 25 | 4 | M40312 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.42e-05 | 721 | 25 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.54e-04 | 722 | 25 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.85e-04 | 747 | 25 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.85e-04 | 747 | 25 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.11e-04 | 255 | 25 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 162 | 25 | 4 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 162 | 25 | 4 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 162 | 25 | 4 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 162 | 25 | 4 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-06 | 169 | 25 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.93e-06 | 180 | 25 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.00e-06 | 181 | 25 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-06 | 184 | 25 | 4 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-06 | 188 | 25 | 4 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-06 | 196 | 25 | 4 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-06 | 197 | 25 | 4 | bb35a2b7320fda92e9cd42f536b7bd54e3a73a32 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.20e-06 | 197 | 25 | 4 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.20e-06 | 197 | 25 | 4 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.28e-06 | 198 | 25 | 4 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.37e-06 | 199 | 25 | 4 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 199 | 25 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 199 | 25 | 4 | 1761669ec514fdb4175042f11b9a31fa5687fc2b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 199 | 25 | 4 | a816b0eed80530113b7e720bbd2311a544ed8ed1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 199 | 25 | 4 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-06 | 200 | 25 | 4 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-06 | 200 | 25 | 4 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.46e-06 | 200 | 25 | 4 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 127 | 25 | 3 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 130 | 25 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.54e-05 | 133 | 25 | 3 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.66e-05 | 134 | 25 | 3 | d4b175257c47916ed90cdb5c555c2b26530ce8d5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 142 | 25 | 3 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.61e-05 | 148 | 25 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.92e-05 | 150 | 25 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.07e-05 | 151 | 25 | 3 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.89e-05 | 156 | 25 | 3 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.41e-05 | 159 | 25 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 9.58e-05 | 160 | 25 | 3 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-05 | 162 | 25 | 3 | 8e0f03fcc25b2ea777e8478fbf771699cf93719c | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.94e-05 | 162 | 25 | 3 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.94e-05 | 162 | 25 | 3 | e0417f1242edf71934fe62bccc55c4678f7ff4ac | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 163 | 25 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 165 | 25 | 3 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.05e-04 | 165 | 25 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 167 | 25 | 3 | 2184c2760b6142e62124a2454a552723e20d4f61 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 168 | 25 | 3 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 168 | 25 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.13e-04 | 169 | 25 | 3 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.15e-04 | 170 | 25 | 3 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.15e-04 | 170 | 25 | 3 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 172 | 25 | 3 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.21e-04 | 173 | 25 | 3 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 173 | 25 | 3 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | BL-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 173 | 25 | 3 | 90700a876d997f7c0f7b3899dffcda7fdafee547 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 173 | 25 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 173 | 25 | 3 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 174 | 25 | 3 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 175 | 25 | 3 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.27e-04 | 176 | 25 | 3 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 177 | 25 | 3 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 177 | 25 | 3 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 179 | 25 | 3 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 179 | 25 | 3 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.34e-04 | 179 | 25 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 179 | 25 | 3 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 180 | 25 | 3 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 180 | 25 | 3 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.38e-04 | 181 | 25 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 181 | 25 | 3 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 181 | 25 | 3 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 182 | 25 | 3 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 182 | 25 | 3 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 182 | 25 | 3 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 182 | 25 | 3 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 182 | 25 | 3 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 183 | 25 | 3 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.45e-04 | 184 | 25 | 3 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 184 | 25 | 3 | 49705c8fec565b16216bdf48e83e27521f52d99a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 184 | 25 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 184 | 25 | 3 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-04 | 185 | 25 | 3 | fd51fef8c69e34c72017d8371ab0a0d7be5701f2 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-04 | 185 | 25 | 3 | bea26e369ae91006052b973cd89b4c49afa9e553 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 185 | 25 | 3 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-04 | 185 | 25 | 3 | 2adb32096aa3473f8d417e5ce9e65264beca9b52 | |
| Drug | mant-GTP | 2.22e-05 | 50 | 25 | 3 | CID000128647 | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 5.40e-05 | 192 | 25 | 4 | 2271_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 6779_DN | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 7350_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6360_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 7297_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 3205_UP | |
| Disease | colorectal health | 2.36e-05 | 201 | 25 | 4 | EFO_0008460 | |
| Disease | alcohol dependence measurement | 9.96e-04 | 55 | 25 | 2 | EFO_0007835 | |
| Disease | fibroblast growth factor basic measurement | 1.14e-03 | 59 | 25 | 2 | EFO_0008130 | |
| Disease | squamous cell carcinoma | 1.47e-03 | 67 | 25 | 2 | EFO_0000707 | |
| Disease | p-tau measurement | 1.70e-03 | 72 | 25 | 2 | EFO_0004763 | |
| Disease | gut microbiome measurement, bone density | 1.99e-03 | 78 | 25 | 2 | EFO_0003923, EFO_0007874 | |
| Disease | telomere length | 2.29e-03 | 313 | 25 | 3 | EFO_0004505 | |
| Disease | cerebral amyloid deposition measurement | 2.93e-03 | 95 | 25 | 2 | EFO_0007707 | |
| Disease | sunburn | 2.99e-03 | 96 | 25 | 2 | EFO_0003958 | |
| Disease | suntan | 3.44e-03 | 103 | 25 | 2 | EFO_0004279 | |
| Disease | white matter microstructure measurement | 4.25e-03 | 390 | 25 | 3 | EFO_0005674 | |
| Disease | cutaneous melanoma | 4.70e-03 | 121 | 25 | 2 | EFO_0000389 | |
| Disease | Papillary Renal Cell Carcinoma | 5.25e-03 | 128 | 25 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.25e-03 | 128 | 25 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.25e-03 | 128 | 25 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.25e-03 | 128 | 25 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.25e-03 | 128 | 25 | 2 | C1266044 | |
| Disease | cognitive function measurement | 6.34e-03 | 1434 | 25 | 5 | EFO_0008354 | |
| Disease | cardiovascular disease | 6.59e-03 | 457 | 25 | 3 | EFO_0000319 | |
| Disease | adiponectin measurement | 6.77e-03 | 146 | 25 | 2 | EFO_0004502 | |
| Disease | rosacea severity measurement | 6.86e-03 | 147 | 25 | 2 | EFO_0009180 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.95e-03 | 148 | 25 | 2 | C0279702 | |
| Disease | resting heart rate | 7.04e-03 | 149 | 25 | 2 | EFO_0004351 | |
| Disease | Paroxysmal atrial fibrillation | 7.69e-03 | 156 | 25 | 2 | C0235480 | |
| Disease | Persistent atrial fibrillation | 7.69e-03 | 156 | 25 | 2 | C2585653 | |
| Disease | familial atrial fibrillation | 7.69e-03 | 156 | 25 | 2 | C3468561 | |
| Disease | Atrial Fibrillation | 8.08e-03 | 160 | 25 | 2 | C0004238 | |
| Disease | reading and spelling ability | 8.67e-03 | 166 | 25 | 2 | EFO_0005301 | |
| Disease | Diuretic use measurement | 8.97e-03 | 169 | 25 | 2 | EFO_0009928 | |
| Disease | trauma exposure measurement | 9.28e-03 | 172 | 25 | 2 | EFO_0010703 | |
| Disease | serum IgG glycosylation measurement | 9.53e-03 | 523 | 25 | 3 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYWTWFSHIAIWGSI | 1001 | Q9Y2Q0 | |
| VYTVTWLFFGFIWWL | 96 | P48544 | |
| YIMVYTVWTALWVTW | 61 | Q8N8D7 | |
| TVWTALWVTWNVFII | 66 | Q8N8D7 | |
| QVFWESTGRTYWVHW | 411 | Q14999 | |
| YITGYAVWLVLWVTW | 61 | Q5VXU1 | |
| TFGLTLTWLYFWWEV | 51 | Q8WTR4 | |
| GSTAFSTWWLSYWIK | 871 | O15440 | |
| YAFGKFPTVVWTWWI | 176 | P35610 | |
| WRVVYWTSQFLTWIL | 111 | Q68DH5 | |
| VVWPSQLGTLTYFWW | 936 | Q9UPU3 | |
| IWFLFWGCIVSSVWS | 21 | Q9HDB5 | |
| HSWWWAAVSISTVGY | 446 | Q8TDN2 | |
| WYARAWVFWLVSAAT | 281 | Q8N4L1 | |
| IVWSWTYLWTVWFFI | 16 | Q9NRC1 | |
| VWTYISLGASFLLWW | 121 | Q9NP78 | |
| TGSIWEWFRSSWTYK | 261 | Q96S66 | |
| YWTWINHFVIWGSLL | 1026 | P98196 | |
| TLWAAVWVTWNVFII | 66 | Q8IVV8 | |
| ITFYWVDTTEWSKLW | 206 | Q7Z2Z1 | |
| YWWAGTTWYRLTTAA | 181 | Q9UH99 | |
| TTDWVHLWYIWLLVV | 36 | Q4KMG9 | |
| TYWTVFTVGSWLWVI | 121 | Q9C0K7 | |
| WWLGIGWYQFVTLIS | 261 | O94901 | |
| IVYVNGGWSTWTEWS | 256 | O95185 | |
| KIYFVLWWLVSSVIW | 671 | Q8NHX9 |